Back
ProQR Therapeutics NV Vs. Pharming Group Industry Stock Comparison
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
18.99%
Sell
42
PHAR
Pharming Group
Last Price:
7.48
Seasonality Move:
13.41%
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.61. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $7.76. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.61
The current trend is moderately bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $7.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 54.31 | Buy |
| Chaikin Money Flow: | -146694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.47 - 3.93) | Sell |
| Bollinger Bands (100): | (1.54 - 3.18) | Buy |
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 42.78 | Sell |
| Chaikin Money Flow: | 10574 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.88 - 8.8) | Sell |
| Bollinger Bands (100): | (7.59 - 8.61) | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.78 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 2.81 | Buy |
| 200-day SMA: | 2.18 | Buy |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.06 | Buy |
| 200-day EMA: | 2.31 | Buy |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.86 | Sell |
| 20-day SMA: | 8.21 | Sell |
| 50-day SMA: | 8.25 | Sell |
| 200-day SMA: | 9.11 | Sell |
| 8-day EMA: | 7.85 | Sell |
| 20-day EMA: | 8.09 | Sell |
| 50-day EMA: | 8.19 | Sell |
| 200-day EMA: | 9.02 | Sell |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
ProQR Therapeutics NV Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharming Group Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||